Sign in

CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275414423
Phone
(650) 822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 8-K Event Other events
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Executive or director change · Regulation FD disclosure
  13. 4 Option exercise PRESIDENT AND CEO acquired 37,994 shares (option exercise)
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 8-K Event Other events
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. 4 Open-market buy Director bought 3,200 shares at $5.33 ($17,056)
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 8 of 27 · 524 filings